Although infants can synthesize some LC-PUFAs, they might need nutritional support to meet the high demands of rapid growth. Maternal milk contains a certain level of long-chain polyunsaturated fatty acids (LC-PUFAs), i.e., polyunsaturated fatty acids with 20 or 22 carbons, particularly arachidonic acid (AA, 20:4n-6) and DHA (22:6n-3). 1, 2) Therefore, there is a need to incorporate these LC-PUFAs into infant formulas. [3] [4] [5] Fish oil (FO) is rich in DHA and EPA (20:5n-3) and is widely used as a supplement for infant formulas. However, a few randomized clinical trials have suggested that EPA might be unsuitable for infants because it might reduce the level of AA 6, 7) and delay development. 8) A DHA-rich microalgal oil (DMO) free of EPA is therefore sometimes recommended as a supplement for infant formulas. 9) However, this recommendation is controversial, because excess DHA would metabolize to EPA via retroconversion. 1) In the previous study, rat pups from mildly n-3 PUFA-deficient dams showed a small increase in the serum lipid EPA level 3 h after the DMO administration. 10) This suggested that DHA had converted to EPA even in the n-3-deficient condition, although the increment was very small and soon decreased. Since the level of blood fatty acids is temporally reflected in the ingested lipid fatty acid composition and the liver metabolites, the consequence of long-term supplementation and whether EPA would be detected in other tissues is of interest. We therefore investigated the recovery of n-3 LC-PUFA in the serum and liver as a consequence of long-term DMO supplementation in this study.
All procedures were performed according to the Guidelines for Animal Experiments of Tohoku University (Decision of the University President, March 24, 1988; revised on September 13, 1994) . Pregnant Sprague-Dawley rats (day 0 of gestation) were purchased from Japan SLC (Hamamatsu, Japan) and divided into two groups on the day of arrival. They were fed on an n-3 fatty acid-deficient diet (n ¼ 6) or a control diet (n ¼ 2) throughout the gestation and lactation period. These diets were based on the AIN 93G diet, and the fat sources in the n-3 fatty acid-deficient diet were a mixture of peanut oil and safflower oil (56% linoleic acid, 28% monoenoic acid and 16% saturated fatty acids). At 4 of age, the pups were weighed and culled to eight individuals. Three male pups born to the each dam that had been fed the n-3 fatty acid-deficient diet were assigned 3 groups, i.e., FO, DMO, and nonadministration. Male pups from the control dams were administered an oil-free vehicle and used as positive y To whom correspondence should be addressed. Fax: +81-22-717-8905; E-mail: f kimura@biochem.tohoku.ac.jp Abbreviations: AA, arachidonic acid; DHA, docosahexaenoic acid; DMO, DHA-rich microalgal oil; DPA, docosapentaenoic acid; EPA, eicosapentaenoic acid; FO, fish oil; LC-PUFA, long-chain polyunsaturated fatty acid; PL, phospholipid; TG, triacylglycerol controls. FO (Nippon Suisan Kaisha, Tokyo, Japan) and DMO (Martek Biosciences Co., Columbia, MD, USA) were emulsified in 1% sodium carboxymethylcellulose (Cellogen F; Dai-Ichi Kogyo Seiyaku Co., Kyoto, Japan) at a 20% (w/w) concentration. The fatty acid compositions of the oils are shown in Table 1 . The DHA content was 29.3% in FO and 50.0% in DMO. FO contained 7.3% of EPA, but DMO contained very little (0.1%). Five ml of the emulsion per gram of the pup's weight was orally administered to the pups from 5 to 21 of age (weaning date). After weaning, the pups were given the same diet as their dams. At 28 of age, i.e., after a 1-week washout period, serum was collected by decapitation after 12 h of food deprivation, and the livers were removed. Total lipids in the serum and liver were extracted by using the Bligh-Dyer method.
11) Serum PL and TG were purified by TLC. Fatty acid methyl esters of the lipids were prepared by using sodium methoxide and analyzed by GLC.
12) The levels of EPA, docosapentaenoic acid (DPA, 22:5n-3), and DHA in the experimental groups are each expressed as the relative ratio to the value for the control group.
The body weight gain and final body and tissue weights did not differ among the three groups. The contents of EPA, DPA, and DHA in the serum and liver lipids of the control group were 0.4-3.3%, 1.5-3.6%, and 2.2-11.2%, respectively, as shown in Table 2 . The serum EPA ratio of the DMO group was less than 1.0, meaning that it was lower than that of the control group (Fig. 1) . In contrast, the relative ratio of liver EPA in the DMO group to the value of the control group was nearly 1.0, i.e., DMO supplementation maintained the liver EPA level at that of the control diet. The EPA ratio of the FO group was lower than 1.0 in both the tissue and Fig. 1 . Recovery of Serum and Liver n-3 LC-PUFAs after Supplementation with n-3 LC-PUFA Rich Oil. Rat pups raised by mildly n-3 PUFA-deficient dams were orally administered with n-3 LC-PUFA rich oil, i.e., FO, fish oil; and DMO, DHA-rich microalgal oil. No oil represents the negative control, i.e., the rat pups did not receive supplementary oil. n-3 LCPUFAs of serum and liver PL and TG are each expressed as the ratio to the value for the control group (pups raised by AIN93G-fed dams).
Ã P < 0:05, significantly different by Student's t-test from the value for the control group. lipid fractions. These results are inconsistent with the concept that orally ingested DHA was not converted to EPA, because FO contained a substantial amount of EPA, although DMO contained very little. Similarly, the DPA ratio in the serum TG of the DMO group was nearly 1.0, although DMO contained very little DPA. These results suggest that ingested DHA might have been retroconverted to DPA and EPA, and that these fatty acids might have accumulated in the rat pups. Several researchers have reported that DHA could be a substrate for metabolic retroconversion to EPA and DPA through a -oxidation reaction. 1) In this study, the serum EPA level did not recover in either the DMO group or FO group, while the previous short-term administration study shows that DMO caused a brief increase of serum EPA. 10) As the increment of serum EPA was temporal in the previous result, serum EPA might have vanished in this n-3 fatty acid-deficient and supplementation condition. The finding that EPA recovered notably in the liver of the DMO group is therefore particularly noteworthy, because there has been little investigation of this in tissues. As the metabolic turnover of serum and liver lipids is active and rapid, 13) determination of the EPA and DPA levels in other tissues would be necessary to confirm whether EPA and DPA had actually been synthesized and accumulated.
The DHA ratio of the DMO group exceeded 1.0. This result did not contradict those of earlier studies, which have reported that DHA supplementation could increase DHA to some extent in the plasma and tissues. 1, 14) The DHA ratio of the FO group was nearly 1.0, but not that of liver TG in this study. The differences in results between the DMO group and the FO group may have been caused by the difference in total n-3 LC-PUFA amount in the oil. As already indicated, the EPA and DPA levels of the FO group were not increased. The dosage of FO used in this study seems to have been insufficient for complete recovery from n-3 PUFA deficiency. Therefore, EPA in FO might have been preferentially converted to DHA under n-3 PUFAdeficient conditions.
In this study, rat pups born to mildly n-3 PUFAdeficient dams received supplemental FO or DMO, and tissue n-3 LC-PUFAs were determined. The recovery of liver EPA and serum DPA in the DMO group indicates the retroconversion of DHA in the infant rats. Low EPA and DPA in the FO group indicates that orally ingested EPA would be metabolized to DHA under n-3 PUFAdeficient conditions, if the ingested amount was appropriate. These results might show that it would be unnecessary to select alternative forms of EPA-free n-3 LC-PUFA enrichment from the point of view of EPA content if an appropriate amount was supplemented.
